Clear Harbor Asset Management, LLC Adamis Pharmaceuticals Corp Transaction History

Clear Harbor Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$0.4 - $1.01 $400 - $1,010	-1,000 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$0.52 - $1.45 $520 - $1,450	1,000 New	1,000 $0
Q1 2020 May 08, 2020	SELL	$0.33 - $0.89 $330 - $890	-1,000 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$0.51 - $1.26 $510 - $1,260	1,000 New	1,000 $0

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.